Farber lipogranulomatosis type 1-Late presentation and early death in a Croatian boy with a novel homozygous ASAH1 mutation

被引:9
作者
Cvitanovic-Sojat, L. [1 ]
Juraski, R. Gjergja [1 ]
Sabourdy, F. [2 ,3 ]
Fensom, A. H. [4 ]
Fumic, K. [5 ]
Paschke, E. [6 ]
Levade, T. [2 ,3 ]
机构
[1] Univ Hosp Sestre Milosrdnice, Dept Pediat, Zagreb 10000, Croatia
[2] CHU Purpan, Dept Metab Biochem, Toulouse, France
[3] CHU Purpan, INSERM, U858, Toulouse, France
[4] Guys Hosp, Genet Ctr, London SE1 9RT, England
[5] Univ Hosp Ctr Rebro, Lab Metab Dis, Zagreb, Croatia
[6] Graz Univ, Dept Pediat, Lab Metab Dis, A-8010 Graz, Austria
关键词
Farber lipogranulomatosis type 1; Acid ceramidase; Joint swelling; Cherry-red spot; Hoarseness; Subcutaneous nodules; CERAMIDASE DEFICIENCY; DISEASE; TURNOVER; CELLS;
D O I
10.1016/j.ejpn.2010.06.002
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: We report a boy with an unusually late presentation of Farber lipogranulomatosis type 1. Case study: The first symptoms appeared at the end of the first year of life in the form of joint swelling; other symptoms such as cherry-red spot, hoarseness, subcutaneous nodules appeared much later. The history of the disease, from the first symptoms till his early death, lasted 26.5 months. The neuronal dysfunction accompanied by the rapid neurological deterioration with seizures and myoclonias, rather than the general dystrophy, seemed to limit the duration of disease in our patient and provoked his early death. Diagnosis was confirmed by analysis of ceramide metabolism in cultured fibroblasts and of the ASAH1 gene, which indicated homozygosity for a novel point mutation. Conclusion: The deficient activity of acid ceramidase correlated well with poor prognosis of the disease in our boy, in contrast to late appearance of dermal nodules and the subsequent severe clinical course with fatal outcome. Farber lipogranulomatosis should be suspected in children with joint swelling as the first and only symptom of disease. In order to advance our knowledge towards establishing genotype phenotype correlations in Farber's disease, detailed analysis of the ASAH1 gene is needed. (C) 201.0 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:171 / 173
页数:3
相关论文
共 5 条
  • [1] Molecular analysis of acid ceramidase deficiency in patients with Farber disease
    Bär, J
    Linke, T
    Ferlinz, K
    Neumann, U
    Schuchman, EH
    Sandhoff, K
    [J]. HUMAN MUTATION, 2001, 17 (03) : 199 - 209
  • [2] Farber lipogranulomatosis: clinical and molecular genetic analysis reveals a novel mutation in an Indian family
    Devi, Akela Radha Rama
    Gopikrishna, Munimanda
    Ratheesh, Raman
    Savithri, Gorinabele
    Swarnalata, Gowrishankar
    Bashyam, Murali
    [J]. JOURNAL OF HUMAN GENETICS, 2006, 51 (09) : 811 - 814
  • [3] NEURODEGENERATIVE COURSE IN CERAMIDASE DEFICIENCY (FARBER-DISEASE) CORRELATES WITH THE RESIDUAL LYSOSOMAL CERAMIDE TURNOVER IN CULTURED LIVING PATIENT CELLS
    LEVADE, T
    MOSER, HW
    FENSOM, AH
    HARZER, K
    MOSER, AB
    SALVAYRE, R
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1995, 134 (1-2) : 108 - 114
  • [4] SULFATIDE AND SPHINGOMYELIN LOADING OF LIVING CELLS AS TOOLS FOR THE STUDY OF CERAMIDE TURNOVER BY LYSOSOMAL CERAMIDASE - IMPLICATIONS FOR THE DIAGNOSIS OF FARBER-DISEASE
    LEVADE, T
    TEMPESTA, MC
    MOSER, HW
    FENSOM, AH
    HARZER, K
    MOSER, AB
    SALVAYRE, R
    [J]. BIOCHEMICAL AND MOLECULAR MEDICINE, 1995, 54 (02) : 117 - 125
  • [5] LEVADE T., 2009, SCRIVER'S OMMBID (ONLINE METABOLIC AND MOLECULAR BASES OF INHERITED DISEASE)